Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine (Q38445877)
Jump to navigation
Jump to search
scientific article published on 19 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine |
scientific article published on 19 October 2013 |
Statements
1 reference
Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine (English)
1 reference
Chang Kyun Lee
Hyun-Soo Kim
Kang-Moon Lee
You Sun Kim
Hyo-Jong Kim
Suk-Kyun Yang
Won Moon
Ja-Seol Koo
Suck-Ho Lee
Geom Seog Seo
Soo Jung Park
Sung-Ae Jung
Sung Noh Hong
Jong Pil Im
Eun Soo Kim
Korean Association for the Study of Intestinal Diseases (KASID) Study
19 October 2013
1 reference